Accretion Pharmaceuticals Share Price Today | Stock Price & Accretion Pharmaceuticals Share Screener
Track the current Accretion Pharmaceuticals share price and stock price live with TickJournal's free stock screener. Check Accretion Pharmaceuticals yearly highs lows for the annual price range and momentum. Use the Accretion Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Accretion Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Accretion Pharmaceuticals Share Price Chart
Track the current stock price of Accretion Pharmaceuticals with an interactive chart. Analyse ACCPL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Accretion Pharmaceuticals stock quote in one place.
Accretion Pharmaceuticals Company Profile - Fundamental Screener
Screen Accretion Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ACCPL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0T8T01010.
Company Details
Classification
Identifiers and Leadership
Accretion Pharmaceuticals Balance Sheet Screener
Screen ACCPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹77, up from ₹40 in 2025.
Latest statistics put total assets at ₹77 and shareholder funds at ₹55, with a leverage ratio of 0.38.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
Assets |
|||
| Total Assets | 77 | 40 | 27 |
| Current Assets | 60 | 33 | 22 |
| Fixed Assets | 13 | 6 | 5 |
Liabilities |
|||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 55 | 15 | 6 |
| Share Capital | 11 | 8 | 4 |
| Reserves & Surplus | 44 | 7 | 2 |
Accretion Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Accretion Pharmaceuticals income statement and profit fundamentals. Analyze ACCPL quarterly results. Accretion Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹90 and net profit of ₹10.
| Item | None-None | 2026-March | 2025-March | 2024-March |
|---|---|---|---|---|
Revenue and Expenses | ||||
| Revenue | 0 | 90 | 58 | 13 |
| Expenses | 0 | 75 | 46 | 11 |
Operating Costs and Margins | ||||
| EBITDA | 0 | 15 | 12 | 3 |
| Operating Profit % | 0.00% | 17.00% | 21.00% | 19.00% |
| Depreciation | 0 | 1 | 1 | 0 |
| Interest | 0 | 1 | 1 | 0 |
Profit and Earnings | ||||
| Profit Before Tax | 0 | 13 | 10 | 2 |
| Tax | 0 | 3 | 3 | 1 |
| Net Profit | 0 | 10 | 7 | 2 |
| EPS | 0.00 | 9.03 | 8.48 | 1.96 |
Accretion Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen ACCPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹15, and net cash flow was an inflow of ₹4.
Over the same period, investing activities used ₹9 and financing activities provided ₹27.
| Item | 2026-March | 2025-March | 2024-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | -15 | -1 | -12 |
| Investing Activities | -9 | -2 | -6 |
Financing and Net Cash | |||
| Financing Activities | 27 | 2 | 17 |
| Net Cash Flow | 4 | 0 | 0 |
Accretion Pharmaceuticals Shareholding Pattern Screener
See Accretion Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Accretion Pharmaceuticals promoter holding and ownership changes for ACCPL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 73.52%, foreign institutions 0.00%, domestic institutions 2.76% and the public 20.22%, spread across 776 shareholders.
The shareholder count was 776 in 2026-Jun, compared with 1,182 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-May | 2025-Jan | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 73.52% | 73.52% | 73.52% | 73.52% | 73.50% | 73.50% | 100.00% | 100.00% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 2.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.22% | 22.92% | 22.01% | 22.85% | 21.46% | 19.44% | 0.00% | 0.00% |
| Other Holding | 3.50% | 3.56% | 4.47% | 3.63% | 5.04% | 7.06% | 0.00% | 0.00% |
| Shareholder Count | 776 | 1,182 | 1,179 | 1,498 | 1,628 | 8 | 8 | 8 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Accretion Pharmaceuticals. Accretion Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.
Accretion Pharmaceuticals Stock Index Membership - Nifty & Sensex
See which indices include Accretion Pharmaceuticals stock. Check ACCPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Accretion Pharmaceuticals Market Events Screener - Corporate Actions
Get Accretion Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Accretion Pharmaceuticals stock events that may affect ACCPL share price, along with derivatives, futures and options activity and sector gainers.
3 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 8, 2026, with a record date of May 8, 2026.
It is followed by Quarterly Result Announcement dated November 14, 2025 and Quarterly Result Announcement dated June 11, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-08 | 2026-05-08 | Quarterly Result Announcement | NA | 3.54% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 16.56% |
| 2025-06-11 | 2025-06-11 | Quarterly Result Announcement | NA | 5.68% |
Accretion Pharmaceuticals Competitors Screener - Peer Stocks Comparison
Screen ACCPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 435,863 | 36.83 | 61,674 | 12.69% | 11,565 | 38.95 |
| Divis Laboratories | 246,660 | 86.00 | 11,067 | 13.95% | 2,568 | 53.27 |
| Torrent Pharmaceuticals | 182,577 | 86.72 | 13,886 | 20.34% | 2,138 | 42.82 |
| Zydus Life Science | 115,910 | 25.96 | 27,658 | 17.64% | 5,026 | 51.33 |
| Cipla | 108,738 | 33.29 | 29,045 | 2.24% | 3,870 | 35.23 |
| Laurus Labs | 106,982 | 98.39 | 6,868 | 22.01% | 890 | 58.13 |
| Mankind Pharma | 103,418 | 50.84 | 14,636 | 14.85% | 1,938 | 59.40 |
| Dr Reddys Laboratories | 102,916 | 32.77 | 35,059 | 3.90% | 4,158 | 62.37 |
| Aurobindo Pharma | 96,203 | 26.41 | 34,145 | 5.56% | 3,503 | 49.32 |
| Lupin | 92,839 | 16.97 | 29,039 | 26.75% | 5,356 | 31.32 |
Accretion Pharmaceuticals Company Announcements - News & Reports Screener
Screen ACCPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 4.29. Market capitalisation stands at ₹237.88 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.